Evan Drozd, ANDRO (2018 MDIC Graduate) Gains Patent for New Spinal Device
Posted Friday, October 22, 2021 9:00 am by The Rome Sentinel
A Rome-based startup subsidiary is aiming to improve the quality of life for individuals suffering from chronic back injuries and has received a patent for its spinal medical device.
AcceliPHI, LLC utilizes office and laboratory space at ANDRO Computational Solutions LLC at the Beeches Business Park. The subsidiary hopes to expand its prototyping labs within the coming 12-18 months.
“Over half of the United States population suffers from chronic back injuries causing pain and discomfort, including a considerable and growing population of patients with scoliosis,” stated AcceliPHi’s lead and primary inventor Evan Drozd.
“Although surgical and other therapeutic interventions can work, in many cases, such treatments can be limited or provide short term benefits, calling for new
interventions to be examined,” added Drozd.
The patented prototype is in the process of being designed, fabricated, and tested in wearable form in cooperation with AcceliPHI’s medical and industry partners, offering a novel alternative for orthopedic surgeons, physical and occupational therapists, chiropractors, and other health specialists to help improve the quality of life for their patients, the company said in a release.
AcceliPHI is also in the process of exploring U.S. Food and Drug Administration approval, including conducting clinical trials, for future device distribution and sales.
According to Drozd, AcceliPHI will next study how the same technology, working in conjunction with biometric sensors, could be used in wearable form to treat other injury sites such as neck and limb joints, to augment existing therapeutic methods.
“Our five-year plan is to develop and deliver new wearables to market with the goal of expanding the versatility of options and alternatives to invasive
treatments and place more tools in the hands of health professionals to improve patient outcomes post-surgery or after other therapies have been exhausted,” Drozd said.
“The patient is our number-one priority, and we want to work with medical practitioners to understand how to optimize the treatment of patients’ pain points,” Drozd added.
AcceliPHI is also researching ways to scale the device for possible implantation using minimally invasive surgery to treat local vertebral, joint, or other body sites,” Drozd said.